TP53 and angiosarcoma: AACR GENIE does provide data on angiosarcoma of the breast and liver, and in our analysis, TP53 mutations were significantly more frequent in liver angiosarcoma compared to breast angiosarcoma (n = 9 vs. n = 4; p = 0.0456).